Vaccines and Infectious Diseases
Informed consent process enhancement approaches for research participants who may be considered vulnerable populations
Go back to Resource Center
Informed consent process enhancement approaches for research participants who may be considered vulnerable populations
Authors:
Secondary:
Location:
Keywords:
Abstract:
Challenges in implementing and managing clinical trials in developing countries: lessons learned by the national cancer institute's (NCI) AIDS malignancy consortium (AMC)
Go back to Resource Center
Challenges in implementing and managing clinical trials in developing countries: lessons learned by the national cancer institute's (NCI) AIDS malignancy consortium (AMC)
Authors:
Secondary:
Location:
Keywords:
Abstract:
Developing a comprehensive site selection process for a cancer network in a resource-limited settings in sub-Saharan Africa
Go back to Resource Center
Developing a comprehensive site selection process for a cancer network in a resource-limited settings in sub-Saharan Africa
Authors:
Secondary:
Location:
Keywords:
Abstract:
Transitioning to the remote collection of urine specimens for urine drug screening during COVID-19
Go back to Resource Center
Transitioning to the remote collection of urine specimens for urine drug screening during COVID-19
Authors:
Volume:
Pagination:
Issue:
Journal:
Keywords:
Abstract:
Comparing Web-Based Platforms for Promoting HIV Self-Testing and Pre-Exposure Prophylaxis Uptake in High-Risk Men Who Have Sex With Men: Protocol for a Longitudinal Cohort Study
Go back to Resource Center
Comparing Web-Based Platforms for Promoting HIV Self-Testing and Pre-Exposure Prophylaxis Uptake in High-Risk Men Who Have Sex With Men: Protocol for a Longitudinal Cohort Study
Authors:
Volume:
Pagination:
Issue:
Journal:
PMID:
Keywords:
Abstract:
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adul
Go back to Resource Center
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adul
Authors:
Journal:
PMID:
Keywords:
Abstract:
Pagination
- Previous page
- Page 2
- Next page